NCT02686034 RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks Status COMPLETED Phase NA
NCT02670161 Quality Improvement and Practice Based Research in Neurology Using the EMR Status ENROLLING_BY_INVITATION Phase PHASE4
NCT02665273 Greater Occipital Nerve Block With Bupivacaine for Acute Migraine Status COMPLETED Phase PHASE3
NCT02638103 Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine Status COMPLETED Phase PHASE3
NCT02630459 A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention Status COMPLETED Phase PHASE2
NCT02629861 Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine Status COMPLETED Phase PHASE3
NCT02621931 Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine Status COMPLETED Phase PHASE3
NCT02616978 Retrospective Study on the Use of CEFALY® Device During Migraine Attacks Status COMPLETED Phase N/A
NCT02615314 Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine Status COMPLETED Phase N/A
NCT02614287 A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura Status COMPLETED Phase PHASE3
NCT02614196 Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study Status COMPLETED Phase PHASE3
NCT02614183 Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study Status COMPLETED Phase PHASE3
NCT02609945 Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults Status COMPLETED Phase PHASE1
NCT02583581 Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks Status UNKNOWN Phase NA